Accession Number:

AD1046770

Title:

Development of a Blood-Based Biomarker Panel for Indeterminate Lung Nodules

Descriptive Note:

Technical Report,01 Sep 2015,31 Aug 2016

Corporate Author:

University of Texas MD Anderson Cancer Center Houston United States

Personal Author(s):

• Taguchi,Ayumu

Report Date:

2016-09-01

Pagination or Media Count:

8.0

Abstract:

Lung cancer screening with low-dose CT LDCT has been shown to reduce mortality by 20 , although there are concerns including high false positivity, cost, and radiation exposure. Blood-based markers are a promising and attractive approach to complement LDCT because of the potential to identify those subjects that need to undergo further work-up for their indeterminate nodules. The main objective of my proposed project is to develop a blood-based biomarker panel from three platforms protein, autoantibody and microRNA to distinguish malignant lung nodules from benign lung nodules. We have so far assayed 20 protein markers, 122 autoantibodies, 20 microRNAs, and a metabolite DAS, in the 149 malignant lung nodules and 187 benign lung nodules.

Descriptors:

• lung cancer
• cancer research
• biological markers
• validation
• DIAGNOSTIC IMAGING

Subject Categories:

• Medicine and Medical Research

Distribution Statement:

APPROVED FOR PUBLIC RELEASE